Nice 3600 buck loss but bought and sold IDRA to make up for the loss. Not pumping IDRA. CMG is done as far as I am concerned. I will stick to my biotech's such as CELG, GILD, and BLUE. If BLUE can alter the genes in sickle cell patients this stock will fly. Nice pop on CELG today. Win some lose some. Nature of the market. I would suggest that CMG has seen it's better days. For the longs-LOL
IDRA seems to be advancing towards is potential. Their technology is cutting edge and should provide a nice return. The BB are cool and if I would have kept my 5000 shares of INCY years ago I would not be posting.